[1] Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009 Dec;60 Suppl 7:191-6.
[2] Sikiric P, Seiwerth S, Rucman R, Kolenc D, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865.
[3] Bilic I, Zoricic I, Anic T, Separovic J, et al. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life Sci. 2001 Mar 9;68(16):1905-12.
[4] S Seiwerth, P Sikiric, Z Grabarevic et al. BPC 157’s effect on healing, Journal of Physiology-Paris, Volume 91, Issues 3–5, May–October 1997, Pages 173-178
[5] Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol. 2004 Apr 1;10(7):1032-6.